213 related articles for article (PubMed ID: 16970798)
1. TLR engagement prevents transplantation tolerance.
Chen L; Wang T; Zhou P; Ma L; Yin D; Shen J; Molinero L; Nozaki T; Phillips T; Uematsu S; Akira S; Wang CR; Fairchild RL; Alegre ML; Chong A
Am J Transplant; 2006 Oct; 6(10):2282-91. PubMed ID: 16970798
[TBL] [Abstract][Full Text] [Related]
2. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
3. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
[TBL] [Abstract][Full Text] [Related]
4. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
5. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
Burns AM; Ma L; Li Y; Yin D; Shen J; Xu J; Chong AS
J Immunol; 2009 Feb; 182(3):1314-24. PubMed ID: 19155477
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
van Maurik Av; Herber M; Wood KJ; Jones ND
J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
[TBL] [Abstract][Full Text] [Related]
7. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
[TBL] [Abstract][Full Text] [Related]
8. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
Wu Z; Wang Y; Gao F; Shen X; Zhai Y; Kupiec-Weglinski JW
J Immunol; 2008 Jul; 181(2):1096-102. PubMed ID: 18606661
[TBL] [Abstract][Full Text] [Related]
9. Combined Anti-CD154/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts.
Lin CH; Wang YL; Anggelia MR; Chuang WY; Cheng HY; Mao Q; Zelken JA; Lin CH; Zheng XX; Lee WP; Brandacher G
Am J Transplant; 2016 Jul; 16(7):2030-41. PubMed ID: 26914847
[TBL] [Abstract][Full Text] [Related]
10. Impaired NF-kappaB activation in T cells permits tolerance to primary heart allografts and to secondary donor skin grafts.
Zhou P; Hwang KW; Palucki DA; Guo Z; Boothby M; Newell KA; Alegre ML
Am J Transplant; 2003 Feb; 3(2):139-47. PubMed ID: 12603209
[TBL] [Abstract][Full Text] [Related]
11. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
12. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
van der Touw W; Burrell B; Lal G; Bromberg JS
Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
[TBL] [Abstract][Full Text] [Related]
13. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
[TBL] [Abstract][Full Text] [Related]
14. Short-term MyD88 inhibition ameliorates cardiac graft rejection and promotes donor-specific hyporesponsiveness of skin grafts in mice.
He WT; Zhang LM; Li C; Li SY; Ding ZC; Fang ZM; Meng FY; Chen ZK; Zhou P
Transpl Int; 2016 Aug; 29(8):941-52. PubMed ID: 27125343
[TBL] [Abstract][Full Text] [Related]
15. Skin allograft maintenance in a new synchimeric model system of tolerance.
Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
[TBL] [Abstract][Full Text] [Related]
16. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
17. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
[TBL] [Abstract][Full Text] [Related]
18. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
[TBL] [Abstract][Full Text] [Related]
19. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
[TBL] [Abstract][Full Text] [Related]
20. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]